Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Laos
Laos: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 62.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Laos, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Laos recorded 62.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in 2025.
The figure is down 1.6% on the previous year and down 12.7% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Laos peaked at 78.0% in 2016 and was at its lowest, 0.0%, in 2008.
That places Laos 144th out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 42.9% | 0.0% | 78.0% | 10 |
| 2020s | 62.3% | 58.0% | 67.0% | 6 |
Countries ranked near Laos
- 141 Benin 64.0% compare
- 142 Democratic Republic of Congo 63.0% compare
- 142 Afghanistan 63.0% compare
- 144 Marshall Islands 62.0% compare
- 144 Nigeria 62.0% compare
- 147 North Macedonia 60.0% compare
More health data for Laos
- Un projection of annual infant deaths 317 (2100)
- Heat deaths vs projected death rates 1,260 (2090)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 08, male, interpolated 81,521 (2025)
- Population, male 50.2% (2025)
- Population ages 15-64, female 2.56 million (2025)
- Population ages 0-14, total 2.35 million (2025)
- Age population, age 06, female, interpolated 77,990 (2025)
- Age population, age 06, male, interpolated 81,318 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Laos?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Laos was 62.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Laos?
- The highest recorded value was 78.0% in 2016.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Laos?
- The lowest recorded value was 0.0% in 2008.
- How does Laos rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Laos ranks 144th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Laos?
- Over the last ten years it is down 12.7%. The long-run trend across the full record is volatile.
- Where does this Laos data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).